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Abstract 
 A photo-responsive amide cleavage device was developed based on the asparagine imidation-mediated 
cleavage of peptide bonds during intein-mediated protein splicing. The chemical environment of the 
protein splicing process was mimicked by the incorporation of geminal dimethyl groups and a secondary 
amine unit in asparagine scaffold. Furthermore, the resulting photo-responsive device could induce the 
photo-triggered cleavage of an amide bond by the protection of the secondary amine unit with an o-
nitrobenzyloxycarbonyl group. 
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 Intein proteins,1 which are found in a wide range of unicellular organisms,2 mediate the self-splicing of 
intein-containing proteins to produce intein-removed splicing proteins through sequential N–S(or O), S(or 
O)–S(or O) and S(or O)–N-acyl transfers. The third S(or O)–N-acyl transfer step in this process starts from 
the imide cyclization of an asparagine (Asn) residue at the intein C-terminus, which is followed by the 
transfer of an O(or S)–peptidyl unit to the liberated amino group.3 The progress of this sequence of 
reactions depends on several requirements, including (i) enhancement of the nucleophilicity of the amide 
side chain of the Asn residue; (ii) activation of the scission peptide bond; and (iii) appropriate arrangement 
of the functional groups involved in the reactions. An analysis of the structural basis for this reaction4 
indicated that the appropriate arrangement of several functional units, including a water molecule, assist 
in the cleavage of the amide via an acid-base-catalyzed mechanism (Figure 1).4a 
 
 
Figure 1. Mechanism of acid-base-catalyzed amide cleavage. 
 
Methodologies for photo-induced amide bond cleavage5 and conformational change6 have provided 
powerful tools for the spatiotemporal control of the functions of peptide/proteins. We previously 
developed a stimulus-responsive processing residue (Spr)7 based on a trimethyl-lock system.8,9 This Spr 
system has shown utility in the field of chemical biology and has potential for real-life application.7a,c,e In 
conjunction with our studies on Spr, we also explored the development of an alternative new scaffold. In 
this context, the result of a mechanistic study4 of the third step of the reaction mentioned above inspired 
 us to design a new amide bond cleavage device with a modified Asn structure. In this way, it was 
envisioned that the modifications shown in Figure 2 would provide the structural features necessary to 
affect the cleavage of an amide bond. The incorporation of a pendant secondary amine would provide an 
intramolecular base,10 which could enhance the nucleophilicity of the amide nitrogen. Furthermore, the 
incorporation of geminal dimethyl groups would lead to a Thorpe-Ingold effect,11–13 which would fix the 
conformation of the intein system and assist in the formation of the succinimide ring. Lastly, the masking 
of the basic character of the secondary amine with a photo-sensitive N-protecting group,14 such as o-
nitrobenzyloxycarbonyl (oNBnoc), could provide a simple platform for the development of stimulus-
responsive amide bond cleavage device.  
 
 
Figure 2. Design of an intein-mediated UV-responsive amide cleavage device.  
 
 
Our work toward preparation of a pendant secondary amine capable of responding to UV irradiation 
started from N-ethylethylenediamine (1) (Scheme 1). The reaction of 1 with tert-butyloxycarbonyl 
anhydride (Boc2O) in THF allowed for the selective protection of the primary amino group. The 
subsequent reaction of the secondary amine group with p-nitroformate 215 and triethylamine (Et3N) in 
THF afforded the requisite compound 3 in quantitative yield (over two steps). The trifluoroacetic acid 
(TFA)-mediated removal of the Boc protecting group from 3 gave the pendant amine unit 4a. The 
 synthesis of the Boc-protected pendant unit 4b proceeded via the trifluoroacetylation of the primary amino 
group of 1, followed by the introduction of a Boc group and the subsequent hydrolysis of the 
trifluoroacetyl protecting group.  
 
Scheme 1. Synthesis of the pendant secondary amine 4a and 4b 
 
Reagents and conditions: (i) Boc2O, THF; (ii) 2, Et3N, THF, quant. (two steps); (iii) TFA, CH2Cl2; (iv) 
ethyltrifluoroacetate, CH2Cl2; (v) Boc2O, CH2Cl2; (vi) K2CO3, MeOH, H2O 
 
Scheme 2. (a) Synthesis of the Intein-inspired amide cleavage device 10a and 10b and (b) the preparation 
of a model peptide. 
  
Reagents and conditions: (i) TFA, TES, CH2Cl2; (ii) AllocCl, NaHCO3, THF, H2O; (iii) LiOH, THF, 
H2O; (iv) Ac2O, THF; (v) allyl alcohol, 60% (five steps); (vi) 4a or 4b, PyBrop, DIEA, CH2Cl2; (vii) 
Pd(PPh3)4, N-methylaniline, THF then FmocOSu, DIPEA  
 
PhFl-diMe-Asp(OMe)-OMe 516 was synthesized over three steps from L-Aspartic acid (6) following 
Goodman’s procedure (Scheme 2). The deprotection of the PhFl group in 5 with a mixture of TFA and 
triethyl silane (TES) in CH2Cl2, followed by the protection of the resulting amine with allylchloroformate 
(Alloc-Cl) gave Alloc-diMe-Asp(OMe)-OMe 7. The subsequent hydrolysis of the two methyl esters of 7 
with LiOH in a mixture of THF and H2O gave the corresponding carboxylic acid, which was reacted with 
Ac2O in THF at reflux temperature, followed by an alcoholysis reaction with allyl alcohol to give the α-
allylester Alloc-diMe-Asp(OH)-OAllyl 8 in 60% isolated yield (over five steps). The reaction of the UV-
responsive amine 4a with the sterically-crowded β-carboxylic acid of 8 was accomplished using 
 bromotripyrrolidinophosphonium hexafluorophosphate (PyBrop) and diisopropylethyl amine (DIPEA) in 
CH2Cl2 to yield the fully protected Asn derivative Alloc-diMe-Asn(Et-N-oNBnoc)-OAllyl 9a in 75% 
isolated yield. The conversion of 9a to the corresponding 9-fluorenylmethyloxycarbonyl (Fmoc)-
protected derivative for Fmoc solid-phase peptide synthesis (SPPS) was achieved by the deprotection of 
the allyl and allyloxycarbonyl (Alloc) groups by the treatment of 9a with Pd(PPh)4 and N-methylaniline, 
followed by the Fmoc protection of the resulting amine to give Fmoc-diMe-Asn(Et-N-oNBnoc)-OH 10a 
in 92% isolated yield. The Boc-protected material Fmoc-diMe-Asn(Et-N-Boc)-OH 10b was also prepared 
in a similar manner in 70% isolated yield from 9b. 
With the requisite Asn derivatives in hand, we proceeded to synthesize two model peptides (H-YGGFL-
X-SGFLYGF-NH2 11a and 11b: X = Asn derivatives) to examine the self-processing properties of the 
peptides. The Fmoc protected amino acids were condensed on NovaSyn® TGR resin using 
diisopropylcarbodiimide (DIPCDI) and 1-hydroxybenztriazole (HOBt) in dimethylformamide (DMF) 
except for 10a and 10b. The condensation of compound 10a was achieved using 1-[bis-
(dimethylamino)methylene]1H-1,2,3-triazolo[4,5-β]pyridine-3-oxide hexafluorophosphate (HATU) and 
DIEA in N-methylpyrrolidone (NMP). The completed peptide resins were subsequently exposed to a 
mixture of TFA-ethanedithiol (EDT)-m-cresol-thioanisole-H2O at room temperature for 2 h to give a 
mixture of two peptides with mass values identical to that of the desired material (Figure 3).  
 
 
Figure 3. Possible mechanism for the generation of the byproduct 18.  
  
The origin of the two peptides was attributed to the formation of the succinimide species 12 during the 
activation of 10a, followed by the aminolysis of the succinimide ring by the amino group of the growing 
peptide chain. Given that one of the two possible electrophilic sites in the succinimide ring of 12 was 
sterically crowded by the neighboring geminal dimethyl groups, it was anticipated that the major product 
of this reaction would be desired α-peptide 11a. We envisaged that the benzyl protection of the amide 
nitrogen in 10a would prevent the formation of the succinimide ring.17 However, our attempts to 
synthesize the dimethoxybenzyl (DMB)-protected Asn derivative 13 resulted in failure (Scheme 3). 
Although the condensation of the N-dimethoxybenzyl diamine derivative 14a with 8 gave the desired 
amide 15 in 50% yield, the subsequent exchange of the protecting groups resulted in the release of the 
pendant amine molecule 14a. The failure of this reaction was attributed to the nucleophilic attack of the 
α-carboxylate on the substituted amide. To confirm the structure of peptide 18 as the iso-peptide form, 
the α-amide protected derivative 16, suitable for the straightforward preparation of 18, was prepared from 
the reaction of the β-allyl ester 17 with 14a (Scheme 3). 
 
Scheme 3. Synthetic approach to 13 and the synthesis of the isomeric peptide 18 
 
 Reagents and conditions: (i) 2,4-dimethoxybenzaldehyde, Na2SO4, MeOH; NaBH4; (ii) MsCl, Et3N, 
CH2Cl2 then 14a, 50%; (iii) MsCl, Et3N, THF then 14a, 60%; (iv) Pd(PPh3)4, N-methylaniline, THF then 
FmocOSu, DIPEA, quant. 
 
The resulting imidation-tolerant β-carboxylic derivative 16 was also incorporated into a peptide resin in 
a manner similar to that employed for 11a. The subsequent deprotection of the resin afforded the β-peptide 
18. This result clearly indicated that the major and minor products of the succinimide ring-opening 
reaction described above were 11a and 18, respectively. This result is shown in the HPLC chart in Figure 
3 for the α- and β-peptides, respectively. A peptide sample without a UV-responsive group was also 
synthesized using the Boc-protected secondary amine 10b in a manner similar to that used for 11a. This 
peptide behaved in the same way as the corresponding system containing 10a, in that the deprotection of 
the protected resin afforded a mixture of α- and β-peptides. 
Peptides 19 and 20 were also prepared to determine the effects of the geminal dimethyl groups and 
secondary amine on the outcome of the transformation.18 The Asn-protected derivative without geminal 
dimethyl groups was prepared by the coupling of the β-carboxylic acid of Fmoc-Asp(OH)-OAllyl19 with 
N-DMB-N’-Boc-N’-ethyl ethylenediamine 14b, followed by the removal of the allyl ester. The Fmoc-
based incorporation of the resulting amino acid into the resin was followed by an acidic deprotection step 
to afford the desired peptide 19, where the Asn residue had been successfully modified with a pendant 
secondary amine without the need for the protection of the secondary amine. Notably, no significant side 
reactions, including the hydrolysis of the peptide bonds, were observed during the acidic deprotection and 
HPLC purification stages. The Asn-incorporated peptide 20 was also synthesized as a separate reference 
compound using standard Fmoc protocols. 
We initially investigated the self-processing of these synthetic peptides, as shown in Figure 4. Peptide 
samples were dissolved in a buffered solution (6 M guanidine hydrochloride (Gn·HCl)-0.2 M phosphate), 
 where they were monitored for peptide bond cleavage by HPLC analysis. As expected, the presence of 
both the secondary amine as an intramolecular base and the geminal methyl groups as an inducer of 
cyclization greatly facilitated the cleavage of the peptide bond (Figure 4, Entries 1–3). When a mixture 
of the materials was held at pH 7.4 for 24 h at 37 °C, almost all of the samples went to completion to 
afford a mixture of split peptides consisting of N-half imide peptide 21, C-half peptide 22 and the 
succinimide ring-opened peptides 23 and 24. The results of these comparison experiments clearly show 
that modifications capable of mimicking the environments involved in the intein-induced cleavage of an 
amide bond were responsible for the envisioned artificial amide bond cleavage reaction (Figure 4, Entry 
4).  
 
 
Figure 4. Self-processing reactions of the model peptides. *Internal standard. 
  
Encouraged by the potential utility of 10a as a stimulus-responsive processing device, we next examined 
the photo-responsive cleavage of the peptide bond in the synthetic peptide 11a (Figure 5). When the 
oNBnoc-protected peptide 11a was incubated for 24 h at 37 °C in a mixture of 6 M Gn·HCl and 0.2 M 
phosphate at pH 7.4 without UV irradiation, the material remained almost completely intact. The 
irradiation of the reaction mixture with UV light led to the removal of the oNBnoc group from the 
secondary amine unit to produce peptide 11b, which was split to the processing peptides with about 80% 
cleavage after 24 h. These results clearly indicated that 11a could serve as a stimulus-responsive 
processing device and an alternative to the Spr system based on a trimethyl lock.  
 
 
Figure 5. Photo-responsive peptide bond cleavage. *Internal standard. **Not peptidyl compounds, 
provably derived from deprotected oNBnoc group with UV irradiation. 
 
In conclusion, we achieved the development of the new amide bond cleavage device modeled on the 
intein-mediated protein splicing. The design concept of the device is derived from the mimicking chemical 
 environments involved in the protein splicing. Although preparation of the device and its incorporation 
into peptides are laborious, an important issue in this work is that the incorporation of geminal dimethyl 
groups and a secondary amine unit in asparagine scaffold well imitate the splicing system. Furthermore, 
protection of the secondary amine with the photo-removal group allowed the device to cleave the amide 
bond in response to photo-irradiation. 
 
Experimental Section 
General Information  
All reactions were carried out under an atmosphere of argon. All commercial reagents were used without 
further purification. For column chromatography, silica gel (spherical, natural, 63-210 μm) was used. The 
progress of reactions was monitored by thin layer chromatography using precoated silica gel glass plates 
(0.25 mm) with F254 indicator. Mass spectra (ESI-MS) were obtained using a ToF mass spectrometer. 
1H-NMR and 13C-NMR spectra were measured using a 300 or 400 MHz spectrometer at room temperature 
unless otherwise noted. Chemical shifts were calibrated to the solvent signal. Multiplicities are given as s 
(singlet), d (doublet), br d (broad doublet), t (triplet), br t (broad triplet), q (quartet), m (multiplet) or br m 
(broad multiplet). For HPLC separation, a Cosmosil 5C18-AR-II analytical column (4.6 × 250 mm, flow 
rate 1.0 mL/min) or a Cosmosil 5C18-AR-II semi-preparative column (10 × 250 mm, flow rate 3.0 
mL/min) was employed and eluting products were detected by UV at 220 nm. A solvent system consisting 
of 0.1% TFA aqueous solution (v/v, solvent A) and 0.1% TFA in MeCN (v/v, solvent B) was used for 
HPLC elution. IR spectra and optical rotations were measured using a polarimeter (concentration in g/100 
mL), respectively. Photolysis was performed with the filtered output (>365 nm) of a 3000 mW/cm2 HG-
Xe lamp. 
 
Synthesis of asparagine derivatives  
 2-Nitrobenzyl {2-[(tert-butoxycarbonyl)amino]ethyl}ethyl  carbamate 3. To a solution of N-
ethylethylenediamine (1) (5.37 mL, 50.0 mmol) in THF (100 mL) was added a solution of Boc2O (3.27 
g, 15.0 mmol) in THF (30 mL) dropwise at 0 °C. The reaction mixture was stirred at room temperature 
for 5 h, and then concentrated in vacuo. The obtained residue was subsequently diluted with EtOAc and 
sat. NaHCO3 aq. The obtained mixture was extracted three times with EtOAc. The combined organic layer 
was washed with brine, dried over Na2SO4, filtrated and concentrated in vacuo. The obtained crude 
carbamate (2.82 g, 15.0 mmol, quant., pale yellow powder) was used for a next step without further 
purification. 
The obtained carbamate (2.82 g) in THF (30 mL) was treated with Et3N (1.62 mL, 11.6 mmol) followed 
by 2-nitrobenzyl 4-nitrophenyl carbonate 215 (3.69 g, 11.6 mmol). The reaction mixture was stirred at 
room temperature for 4 h, and then concentrated in vacuo and diluted with EtOAc and 5% KHSO4 aq. 
The obtained mixture was extracted three times with EtOAc. The combined organic layer was washed 
with sat. NaHCO3 aq. and brine, dried over Na2SO4, filtrated and concentrated in vacuo. The crude 
material was purified by column chromatography (n-hexane/EtOAc = 8/1 then 1/1) to afford oNBnoc-
diamine 3 (4.26 g, 11.6 mmol, quant.) as yellow oil. IR (CHCl3): vmax, cm
−1: 1364, 1477, 1529, 1701, 
2875, 2977, 3358; 1H-NMR (DMSO-d6, 100 °C, 300 MHz) δ = 1.09 (3H, t, J = 7.0 Hz), 1.38 (9H, s), 3.11 
(2H, dt, J = 6.6 and 6.6 Hz), 3.22–3.35 (4H, m), 5.39 (2H, s), 6.35–6.47 (1H, br m), 7.60 (1H, dd, J = 8.1 
and 7.5 Hz), 7.67 (1H, d, J = 7.3 Hz), 7.76 (1H, dd, J = 7.3 and 7.5 Hz), 8.05 (1H, d, J = 8.1 Hz); 13C-
NMR (DMSO-d6, 60 °C, 75 MHz) δ = 13.1, 28.0, 41.9, 62.7, 77.5, 124.3, 128.7, 128.8, 132.1, 133.6, 
147.2, 154.5, 155.3; HRMS (ESI-TOF) m/z calcd for C17H25N3NaO6 ([M + Na]
+): 390.1641, found: 
390.1643. 
2-Nitrobenzyl (2-aminoethyl)(ethyl)carbamate 4a. Carbamate 3 (2.00 g, 2.72 mmol) in CH2Cl2 (1.36 
mL) was treated with trifluoroacetic acid (1.36 mL). The reaction mixture was stirred at room temperature 
for 45 min and concentrated in vacuo. After dilution of the resulting residue with EtOAc and sat. NaHCO3 
 aq, the solution was extracted three times with EtOAc. The combined organic layer was washed with 
brine, dried over Na2SO4, filtrated and concentrated in vacuo. Crude oNBoc amine 4a (1.45 g) was 
obtained as yellow powder. The obtained crude 4a was used for preparation of 9a and 14a without further 
purification. 
tert-Butyl (2-aminoethyl)(ethyl)carbamate 4b. To a stirred mixture of N-ethylethylenediamine 1 (2.39 
mL, 22.7 mmol) in CH2Cl2 (50 mL) was added ethyl trifluoroacetate (3.46 mL, 22.7 mmol) in CH2Cl2 
(50 mL) dropwise over 40 min at 0 °C. The reaction mixture was stirred at room temperature for 1 h and 
then concentrated in vacuo. After dilution of the resulting residue with CH2Cl2 (100 mL), to the solution 
was added Boc2O (4.95 g, 22.7 mmol) in CH2Cl2 (5.0 mL) at 0 °C. The reaction mixture was stirred at 
room temperature for 1.5 h and then diluted with EtOAc and sat. NaHCO3 aq. The solution was extracted 
three times with EtOAc. The combined organic layer was washed with brine, dried over MgSO4, filtrated 
and concentrated in vacuo. The obtained crude material in MeOH (90 mL) and H2O (10 mL) was treated 
with K2CO3 (2.00 g). The reaction mixture was refluxed for 2 h and then concentrated in vacuo. The 
mixture was extracted three times with EtOAc. The combined organic layer was washed with H2O and 
brine, dried over MgSO4, filtrated and concentrated in vacuo. Crude Boc amine 4b (4.27 g) was obtained 
as pale yellow oil. The obtained crude 4b was used for preparation of 9b and 14b without further 
purification. 
(S)-3-{[(Allyloxy)carbonyl]amino}-2,2-dimethylsuccinic acid 4-(allyl)ester 8 and (S)-4-(allyloxy)-2-
{[(allyloxy)carbonyl]amino}-3,3-dimethyl-4-oxobutanoic acid 17 To a solution of PhFl-diMe-
Asp(OMe)-OMe 516 (1.83 g, 4.05 mmol) in CH2Cl2 (10.2 mL) was added triethyl silane (1.43 mL, 14.2 
mmol) followed by trifluoroacetic acid (10.2 mL) at 0 °C. The reaction mixture was stirred at room 
temperature for 1 h and concentrated in vacuo. The obtained mixture was diluted with 1 M HCl aq. The 
precipitate was filtrated and washed with MeOH. The filtrate was concentrated in vacuo and the resulting 
crude amine was used for a next step without further purification. 
 The crude amine in THF (12.5 mL) and H2O (8.96 mL) was treated with NaHCO3 (2.51 g, 29.9 mmol) 
followed by allylchloroformate (63.6 μL, 5.98 mmol) at 0 °C. The reaction mixture was stirred at room 
temperature for 9 h and diluted with H2O and EtOAc. The mixture was extracted three times with EtOAc. 
The combined organic layer was washed with brine, dried over Na2SO4, filtrated and concentrated in 
vacuo. The obtained crude Alloc-diMe-Asp(OMe)-OMe 7 was used for next step without further 
purification. 
The crude 7 in THF (10.9 mL) and H2O (30 mL) was treated with 1 M LiOH aq. (17.4 mL, 17.4 mmol) 
at 0 °C. The reaction mixture was stirred at room temperature for 10 h and diluted with CH2Cl2. The 
aqueous layer was washed three times with CH2Cl2 and then acidified (pH ≈ 3) with 3 M HCl aq. To the 
aqueous layer was added EtOAc and NaCl. The mixture was extracted three times with EtOAc. The 
combined organic layer was washed with brine, dried over Na2SO4, filtrated and concentrated in vacuo. 
Crude carboxylic acid (1.22 g) was obtained as colorless oil. 600 mg of it was used for next step without 
further purification. 
The stirred mixture of obtained crude carboxylic acid (600 mg) in THF (2.43 mL) was treated with 
Ac2O (616 μL, 6.56 mmol). The reaction mixture was refluxed for 18 h and then concentrated in vacuo. 
To the obtained crude anhydride was added allylalcohol (7.5 mL). The reaction mixture was stirred at 
room temperature for 23 h and concentrated in vacuo. The obtained crude material was purified by column 
chromatography (chloroform/MeOH = 400/1 then 50/1) to afford 8 (449 mg, 1.47 mmol, 61% over five 
steps from 5) as colorless oil and 17 (131 mg, 0.459 mmol, 19% over five steps from 5) as colorless oil. 
8: [α]28D -12.3 (c 1.56, CHCl3); IR (CHCl3): vmax, cm−1: 1330, 1519, 1713, 2886, 2942, 3084, 3349; 1H-
NMR (CDCl3, 400 MHz) δ = 1.26 (3H, s), 1.37 (3H, s), 4.58–4.67 (5H, m), 5.21–5.27 (2H, m), 5.29–5.36 
(2H, m), 5.66 (br d, J = 9.6 Hz), 5.85–5.98 (2H, m); 13C-NMR (CDCl3, 75 MHz) δ = 22.2, 23.3, 45.7, 
59.8, 66.0, 66.4, 118.2, 118.7, 131.9, 132.5, 156.5, 175.1, 175.3; HRMS (ESI-TOF) m/z calcd for 
C13H19N1NaO6 ([M + Na]
+): 308.1110, found 308.1115. 17: [α]28D -11.8 (c 2.40, CHCl3), IR (CHCl3): 
 vmax, cm
−1:932, 1251, 1525, 1724, 2886, 2944, 2984, 3088, 3350; 1H-NMR (CDCl3, 400 MHz) δ = 1.23 
(3H, s), 1.34 (3H, s), 4.57–4.67 (5H, m), 5.20–5.26 (2H, m), 5.28–5.36 (2H, m), 5.68 (1H, br d, J = 10.4), 
5.81–5.98 (2H, m); 13C-NMR (CDCl3, 75 MHz) δ = 22.1, 23.3, 45.6, 59.9, 66.3, 66.4, 118.2, 119.3, 131.3, 
132.6, 156.4, 170.2, 181.5; HRMS (ESI-TOF) m/z calcd for C25H19N1NaO6 ([M + Na]
+): 308.1110, found: 
308.1121. 
Allyl (S)-2-{[(allyloxy)carbonyl]amino}-4-{[2-ethyl(2-nitrobenzyloxycarbonyl)aminoethyl]amino}-
3,3-dimethyl-4-oxobutanoate 9a. To a solution of 8 (34.5 mg, 0.121 mmol) in CH2Cl2 (605 μL) were 
added crude 4a (93.8 mg), bromotri(pyrrolidino)phosphonium hexafluorophosphate (PyBrop) (152 mg, 
0.454 mmol) and N,N-diisopropylethylamine (DIPEA) (77.2 μL, 0.454 mmol) at 0 °C. The reaction 
mixture was stirred at room temperature for 34 h and then diluted with EtOAc and 5% KHSO4 aq. The 
solution was extracted three times with EtOAc. The combined organic layer was washed with sat. 
NaHCO3 aq., dried over Na2SO4, filtrated and concentrated in vacuo. The obtained crude material was 
purified with column chromatography (n-hexane/EtOAc = 1/1 then 1/2) to afford amide 9a (48.0 mg, 90.4 
μmol, 75%) as colorless oil. [α]28D -2.9 (c 1.25, CHCl3); IR (CHCl3): vmax, cm−1: 1268, 1342, 1427, 1526, 
1650, 1703, 2875, 2939, 2973, 3079, 3361; 1H-NMR (DMSO-d6, 70 °C, 300 MHz) δ = 1.08 (3H, t, J = 
7.1 Hz), 1.13 (3H, s), 1.14 (3H, s), 3.19–3.35 (6H, m), 4.46–4.59 (5H, m), 5.13–5.24 (2H, m), 5.24–5.36 
(2H, m), 5.4 (2H, s), 5.81–5.98 (2H, m), 7.16 (1H, br d, J = 2.9 Hz), 7.46–7.55 (1H, br m), 7.60 (1H, dd, 
J = 7.1, 8.0 Hz), 7.69 (1H, br d, J = 7.2 Hz), 7.78 (1H, dd, J = 7.1, 7.2 Hz), 8.07 (1H, d, J = 8.0 Hz); 13C-
NMR (DMSO-d6, 70 °C, 75 MHz) δ =13.0, 21.1, 22.6, 37.7, 41.8, 44.1, 45.3, 59.7, 62.7, 64.4, 64.5, 116.6, 
117.4, 124.2, 128.7, 128.9, 131.9, 132.0, 133.1, 147.3, 154.5, 155.7, 169.7, 174.6; HRMS (ESI-TOF) m/z 
calcd for C25H34N4NaO9 ([M + Na]
+): 557.2223, found: 557.2244. 
(S)-2-{[(9H-Fluoren-9-yl)methoxycarbonyl]amino}-4-{[2-ethyl(2-nitrobenzyloxycarbonyl)amino 
ethyl]amino}-3,3-dimethyl-4-oxobutanoic acid 10a. To a stirred mixture of 9a (20.2 mg, 37.4 μmol) in 
THF were added Pd(PPh3)4 (6.49 mg, 5.61 μmol) and N-methylaniline (40.8 μL, 0.374 mmol). The 
 reaction mixture was stirred at room temperature for 6 h. To the reaction mixture were added DIPEA 
(15.3 μL, 89.8 μmol) and FmocOSu (15.1 mg, 44.9 μmol) at 0 °C. The reaction mixture was stirred at 
room temperature for 10 h and diluted with EtOAc and 5% KHSO4 aq. The solution was extracted three 
times with EtOAc. The combined organic layer was washed with brine, dried over Na2SO4, filtrated and 
concentrated in vacuo. The obtained crude material was purified with column chromatography 
(CHCl3/MeOH = 150/1 then 30/1) to afford carboxylic acid 10a (21.7 mg, 34.3 μmol, 92%) as pale yellow 
oil. [α]28D -1.1 (c 1.30, CHCl3); IR (CHCl3): vmax, cm−1: 930, 1249, 1367, 1530, 1672, 1726, 2875, 2934, 
2975, 3079, 3350; 1H-NMR (CDCl3, 50 °C, 300 MHz) δ = 1.03–1.20 (6H, m), 1.25 (3H, s), 3.30 (2H, q, 
J = 7.1 Hz), 3.34–3.57 (4H, m), 4.18 (1H, t, J = 6.8 Hz), 4.37 (2H, d, J = 6.8 Hz), 4.42–4.58 (1H, m), 5.47 
(2H, s), 6.03–6.13 (1H, m), 6.79–6.94 (1H, m), 7.24–7.61 (9H, m), 7.71 (2H, d, J = 7.5 Hz), 7.98 (1H, d, 
J = 7.9 Hz); 13C-NMR (CDCl3, 75 MHz) δ =13.9, 23.2, 23.6, 40.7, 43.0, 45.5, 45.9, 47.3, 60.0, 64.7, 67.5, 
120.1, 125.2, 125.3, 127.2, 127.9, 128.9, 129.1, 129.3, 132.3, 133.8, 141.4, 143.8, 143.9, 147.9, 149.0, 
156.9, 157.6, 172.3; HRMS (ESI-TOF) m/z calcd for C33H37N4O9 ([M + H]
+): 633.2561, found: 633.2549. 
Allyl (S)-2-{[(allyloxy)carbonyl]amino}-4-{[2-(tert-butoxy carbonyl)(ethyl)aminoethyl]amino}-3,3-
dimethyl-4-oxobutanoate 9b. Amide 9b was prepared from carboxylic acid 8 (72.0 mg, 0.252 mmol) and 
crude 4b (96 mg) in a manner similar to that described for preparation of 9a. 9b (109 mg, 0.239 mmol, 
95%) was obtained as colorless oil. [α]28D -6.7 (c 2.18, CHCl3); IR (CHCl3): vmax, cm−1: 1341, 1431, 1525, 
1709, 2880, 2934, 2975, 3317; 1H-NMR (CDCl3, 400 MHz) δ = 1.10 (3H, t, J = 7.0 Hz), 1.25 (3H, s), 
1.35 (3H, s), 1.46 (3H, s), 3.21 (2H, q, J = 7.0 Hz), 3.28–3.50 (4H, br m), 4.32 (2H, d, J = 9.2 Hz), 4.57 
(2H, ddd, J = 1.6, 1.6, 5.6 Hz), 4.60 (2H, ddd, J = 1.6, 1.6, 5.6 Hz), 5.16–5.25 (2H, m), 5.26–5.35 (2H, 
m), 5.82–5.97 (2H, m), 6.38 (2H, br d, J = 9.2 Hz), 7.05–7.20 (1H, br m); 13C-NMR (CDCl3, 75 MHz) δ 
=13.9, 23.5, 24.6, 28.6, 41.1, 43.0, 44.5, 45.5, 61.3, 65.9, 80.3, 117.6, 118.6, 131.8, 132.9, 156.5, 157.6, 
170.6, 176.3; HRMS (ESI-TOF) m/z calcd for C22H37N3NaO7 ([M + Na]
+): 478.2529, found: 478.2539. 
 (S)-2-{[(9H-Fluoren-9-yl)methoxycarbonyl]amino}-4-{[2-(tert-butoxycarbonyl)(ethyl)aminoethyl] 
amino}-3,3-dimethyl-4-oxobutanoic acid 10b. Carboxylic acid 10b was prepared from amide 9b (88.8 mg, 
0.195 mmol) in a manner similar to that described for 10a. 10b (72.2 mg, 0.136 mmol, 70%) was obtained 
as pale yellow oil. [α]28D -1.0 (c 2.16, CHCl3); IR (CHCl3): vmax, cm−1: 1366, 1450, 1479, 1531, 1709, 
2875, 2934, 2975, 3329; 1H-NMR (CDCl3, 400 MHz) δ = 1.11 (3H, t, J =7.2 Hz), 1.24 (3H, s), 1.36 (3H, 
s), 1.46 (9H, s), 3.22 (2H, q, J = 7.2 Hz), 3.3–3.47 (4H, m), 4.22 (1H, t, J = 7.2 Hz), 4.30 (2H, d, J = 7.2 
Hz), 4.56 (1H, br d, J = 8.0 Hz), 6.11–6.26 (1H, br m), 7.31 (2H, dd, J = 7.6, 7.6 Hz), 7.39 (2H, dd, J = 
9.2, 7.6 Hz), 7.57–7.65 (2H, m), 7.75 (2H, d, J = 9.2 Hz), 7.77–7.85 (1H, br m); 13C-NMR (CDCl3, 75 
MHz) δ =13.8, 23.4, 23.7, 28.5, 41.5, 43.2, 45.3, 45.5, 47.3, 60.1, 67.4, 80.8, 120.1, 125.3, 127.2, 127.8, 
141.4, 143.8, 144.0, 156.8, 157.8, 172.1, 178.9; HRMS (ESI-TOF) m/z calcd for C30H39N3NaO7 ([M + 
Na]+): 576.2686, found: 576.2672. 
2-Nitrobenzyl {2-[(2,4-dimethoxybenzyl)amino]ethyl}(ethyl)carbamate 14a. Crude amine 4a (1.24 g) 
in MeOH (8.9 mL) was treated with 2,4-dimethoxybenzaldehyde (1.23 g, 7.41 mmol), AcOH (278 μL, 
4.86 mmol) and Na2SO4 (3.29 g, 46.3 mmol). The reaction mixture was stirred at room temperature for 2 
h. To the reaction mixture was added NaBH4 (700 mg, 18.5 mmol) at 0 °C. The reaction mixture was 
additionally stirred at room temperature for 1 h and then diluted with sat. NaHCO3 aq. The mixture was 
extracted three times with EtOAc. The combined organic layer was washed with brine, dried over Na2SO4, 
filtrated and concentrated in vacuo. The obtained crude material was purified with column 
chromatography (n-hexane/EtOAc = 2/1 then EtOAc/MeOH 3/1) to afford DMB-oNBnoc amine 14a 
(1.84 g, 4.41 mmol, 95% over two steps) as light brown oil. IR (CHCl3): vmax, cm
−1: 1343, 1423, 1465, 
1529, 1613, 1701, 2836, 2935, 3340; 1H-NMR (DMSO-d6, 80 °C, 300 MHz) δ =1.09 (3H, t, J = 7.0 Hz), 
1.38 (9H, s), 3.11(2H, dt, J = 6.6, 6.6 Hz), 3.21-3.37 (4H, m), 5.39 (2H, s), 6.33-6.48 (1H, br m), 7.60 
(1H, dd, J = 8.1, 7.6 Hz), 7.68 (1H, d, J = 7.3 Hz), 7.76 (1H, dd, J = 7.3, 7.5 Hz), 8.05 (1H, d, J = 8.1 Hz); 
13C-NMR (DMSO-d6, 60 °C, 75 MHz) δ =13.1, 28.0, 38.5, 41.9, 46.1, 62.7, 77.5, 124.3, 128.7, 128.8, 
 132.1, 133.6, 147.2, 154.5, 155.3; HRMS (ESI-TOF) m/z calcd for C21H28N3O6 ([M + Na]
+): 418.1978, 
found: 418.1988. 
tert-Butyl {2-[(2,4-dimethoxybenzyl)amino]ethyl}(ethyl)carbamate 14b. DMB-Boc amine 14b was 
prepared from amine crude 4b (500 mg) and 2,4-dimethoxybenzaldehyde (221 mg, 1.33 mmol) in a 
manner similar to that described for 14a. 14b (396 mg, 1.17 mmol, 88%) was obtained as yellow oil. IR 
(CHCl3): vmax, cm
−1: 1156, 1366, 1463, 1507, 1613, 1690, 2837, 2933, 2973, 3342; 1H-NMR (DMSO-d6, 
60 °C, 300 MHz) δ = 1.02 (3H, t, J = 7.0 Hz), 1.38 (9H, s), 2.69 (2H, t, J = 6.8 Hz), 3.17 (2H, q, J = 7.0 
Hz), 3.25 (2H, t, J = 6.8 Hz), 3.70 (2H, s), 3.76 (3H, s), 3.78 (3H, s), 6.59 (1H, br s), 6.48 (1H, dd, J = 
8.3, 2.2 Hz), 6.55 (1H, d, J = 2.2 Hz), 7.18 (1H, d, J = 8.3 Hz); 13C-NMR (CDCl3, 75 MHz) δ = 13.6, 
28.5, 42.5, 46.6, 47.3, 48.7, 55.4, 55.5, 70.6, 77.2, 79.4, 98.6, 103.8, 120.2, 130.6, 158.7, 160.3; HRMS 
(ESI-TOF) m/z calcd for C18H31N2O4 ([M + H]
+): 339.2284, found: 339.2281. 
Allyl (S)-2-[(allyloxycarbonyl)amino]-4-[(2,4-dimethoxybenzyl)(2-ethyl-2-nitrobenzyloxycarbonyl 
aminoethyl)amino]-3,3-dimethyl-4-oxobutanoate 15. To a solution of Carboxylic acid 8 (118 mg, 0.413 
mmol) in CH2Cl2 (1.5 mL) was added Et3N (173 μL, 1.24 mmol) followed by the addition of MsCl (38.4 
μL, 0.496 mmol) in CH2Cl2 (100 μL) at 0 °C. The reaction mixture was stirred at same temperature for 2 
h. After addition of 14a (199 mg, 0.476 mmol) in CH2Cl2 (1.5 mL) to the reaction mixture at 0 °C, The 
resulting mixture was stirred at room temperature for additional 17 h and then diluted with EtOAc and 
5% KHSO4 aq. The solution was extracted three times with EtOAc. The combined organic layer was 
washed with sat. NaHCO3 aq. and brine, dried over Na2SO4, filtrated and concentrated in vacuo. The 
obtained crude material was purified with column chromatography (n-hexane/EtOAc = 13/7 then 3/2) to 
afford amide 15 (140 mg, 0.204 mmol, 50%) as colorless oil. [α]29D -0.4 (c 0.80, CHCl3); IR (CHCl3): 
vmax, cm
−1:1208, 1423, 1477, 1528, 1614, 1707, 2838, 2939, 2972, 3084, 3314, 3443; 1H-NMR (DMSO-
d6, 100 °C, 300 MHz) δ = 1.04 (3H, t, J = 7.0 Hz), 1.27 (3H, s), 1.33 (3H, s), 3.21(3H, q, J = 7.0 Hz), 
3.26–3.44 (4H, m), 3.76 (3H, s), 3.78 (3H, s), 4.50–4.64 (7H, m), 5.12–5.24 (2H, m), 5.26–5.38 (4H, m), 
 5.77–6.11 (2H, m), 6.49 (1H, dd, J = 8.4, 2.0 Hz), 6.56 (1H, d, J = 2.0 Hz), 6.85 (1H, br d, J = 9.3 Hz), 
6.99 (1H, d, J = 8.4 Hz), 7.54–7.63 (2H, m), 7.71 (1H, t, J = 7.5 Hz), 8.03 (1H, d, J = 8.1 Hz); 13C-NMR 
(CDCl3, 75 MHz, rotamer)
20 δ = 13.2, 13.9, 24.2, 25.3, 25.5, 29.6, 42.4, 43.1, 43.6, 43.7, 44.1, 44.3, 45.5, 
46.4, 47.6, 55.1, 55.3, 63.2, 63.5, 63.7, 65.7, 98.4, 104.0, 116.6, 117.0, 117.4, 117.5, 117.9, 118.1, 124.8, 
128.2, 128.3, 128.4, 128.5, 128.7, 131.8, 131.9, 132.7, 133.1, 133.2, 133.5, 133.6, 155.0, 155.4, 156.8, 
157.9, 160.2, 160.3, 170.7, 176.2, 176.3, 176.4; HRMS (ESI-TOF) m/z calcd for C34H44N4NaO11 ([M + 
Na]+): 707.2904, found: 707.2924. 
Synthesis of α-amide protected derivatives 16 and 27  
 
Allyl (S)-3-(allyloxycarbonyl)amino-4-{[2,4-dimethoxybenzyl][2-(ethyl-2-nitrobenzyloxycarbonyl 
amino)ethyl]amino}-2,2-dimethyl-4-oxobutanoate 25. Carboxylic acid 17 (90.6 mg, 0.318 mmol) in THF 
(3.1 mL) was treated with Et3N (133 μL, 0.953 mmol). Following to addition of MsCl (29.5 μL, 0.381 
mmol) at 0 °C, the reaction mixture was stirredat same temperature for 30 min. After addition of 14a (199 
mg, 0.476 mmol) to the reaction mixture at 0 °C. The resulting solution was stirred at room temperature 
for additional 20 h and then diluted with EtOAc and 5% KHSO4 aq. The solution was extracted three 
times with EtOAc. The combined organic layer was washed with sat. NaHCO3 aq. and brine, dried over 
Na2SO4, filtrated and concentrated in vacuo. The obtained crude material was purified with column 
chromatography (n-hexane/EtOAc = 2/1 then 1/1) to afford amide 25 (130 mg, 0.190 mmol, 60%) as 
colorless oil. [α]28D -16.8 (c 1.03, CHCl3); IR (CHCl3): vmax, cm−1: 1209, 1343, 1426, 1509, 1529, 1645, 
 1709, 2939, 2976, 3196; 1H-NMR (DMSO-d6, 100 °C, 300 MHz) δ = 1.04 (3H, br t, J = 6.1 Hz), 1.15 
(3H, s), 1.24 (3H, s), 3.13–3.62 (6H, br m), 3.76 (6H, s), 4.33–4.64 (6H, m), 4.74–4.97 (1H, br m), 5.08–
5.23 (2H, m), 5.23–5.34 (2H, m), 5.37 (2H, s), 5.78–6.02 (2H, m), 6.45 (1H, d, J = 8.2 Hz), 6.55 (1H, s), 
6.85 (1H, br d, J = 9.0 Hz), 7.03 (1H, d, J = 8.2 Hz), 7.52–7.67 (2H, m), 7.73 (1H, dd, J = 7.4, 7.4 Hz), 
8.04 (1H, dd, J = 8.1 Hz); 13C-NMR (DMSO-d6, 100 °C, 75 MHz) δ = 12.7, 21.0, 22.5, 41.6, 43.3, 43.4, 
44.9, 45.5, 54.8, 55.1, 55.8, 62.4, 64.1, 64.4, 98.4, 104.7, 116.5, 116.8, 123.9, 128.4, 128.7, 131.6, 132.2, 
132.8, 133.1, 147.3, 154.2, 155.1, 157.9, 159.8, 169.3, 174.6; HRMS (ESI-TOF) m/z calcd for 
C34H44N4NaO11 ([M + Na]
+): 707.2904 found: 707.2933. 
(S)-3-{[(9H-Fluoren-9-yl)methoxycarbonyl]amino}-4-{[2,4-dimethoxybenzyl][2-ethyl(2-nitrobenzyl 
oxycarbonyl)aminoethyl]amino}-2,2-dimethyl-4-oxobutanoic acid 16. Carboxylic acid 16 was prepared 
from amide 25 (55.5 mg, 81.1 μmol) in a manner similar to that described for 10a. 16 (63.0 mg, 80.5 
μmol, quant.) was obtained as pale yellow amorphous. [α]28D -8.2 (c 1.49, CHCl3); IR (CHCl3): vmax, 
cm−1:1342, 1452, 1508, 1526, 1613, 1645, 1708, 2853, 2931, 2961, 3068, 3421; 1H-NMR (DMSO-d6, 
100 °C, 300 MHz) δ = 0.97 (3H, t, J = 7.0 Hz), 1.04 (3H, s), 1.14 (3H, s), 3.12–3.43 (6H, br m), 3.66 (3H, 
s), 3.68 (3H, s), 4.01–4.57 (5H, br m), 4.75 (1H, br d, J = 1.8 Hz), 5.31 (2H, s), 6.34 (1H, dd, J = 8.3, 2.0 
Hz), 6.47 (1H, d, J = 2.0 Hz), 6.84–7.07 (2H, m), 7.16–7.29 (2H, m), 7.34 (2H, dd, J = 7.5, 7.1 Hz), 7.46–
7.72 (5H, m), 7.79 (2H, d, J = 7.5 Hz), 7.97 (1H, 7.9 Hz); 13C-NMR (DMSO-d6, 75 MHz, rotamer)
20 δ = 
13.1, 13.7, 20.8, 21.0, 24.3, 42.2, 42.3, 43.1, 44.9, 45.8, 45.9, 46.7, 55.0, 55.4, 55.6, 55.9, 63.2, 65.9, 98.1, 
98.3, 104.3, 104.5, 116.4, 117.0, 120.2, 124.7, 125.4, 127.0, 127.7, 128.7, 129.0, 132.3, 132.6, 134.1, 
134.2, 140.7, 143.5, 143.7, 143.8, 154.3, 154.7, 156.0, 156.3, 158.0, 158.2, 159.7, 160.2, 169.9, 177.5, 
177.7; HRMS (ESI-TOF) m/z calcd for C42H46N4NaO11 ([M + Na]
+): 805.3061, found: 805.3063. 
 
Allyl (S)-3-[(allyloxycarbonyl)amino]-4-{[2-ethyl(tert-butoxycarbonyl)aminoethyl][2,4-
dimethoxybenzyl]amino}-2,2-dimethyl-4-oxobutanoate 26. Amide 26 was prepared from 17 (63.5 mg, 
 0.223 mmol) and 14b (113 mg) in a manner similar to 25. 26 (74.6 mg, 0.122 mmol, 55%) was obtained 
as colorless oil. [α]28D -1.8 (c 1.07, CHCl3); IR (CHCl3): vmax, cm−1: 1366, 1507, 1646, 1693, 1723, 2832, 
2875, 2934, 2975; 1H-NMR (DMSO-d6, 100 °C, 300 MHz) δ = 0.88–1.11 (3H, m,), 1.16 (3H, s), 1.13 
(3H, s), 1.38 (9H), 3.03–3.60 (6H, br m), 3.77(3H, s), 3.79 (3H, s), 4.38–4.65 (6H, m), 4.84 (1H, br d, J 
= 9.0 Hz), 5.11–5.24 (2H, m), 5.24–5.41 (2H, m), 5.75–6.06 (2H, m), 6.48 (1H, br d, J = 7.7 Hz), 6.57 
(1H, s), 6.83 (1H, br d, J = 9.0 Hz), 7.03 (1H, br d, J = 7.7 Hz); 13C-NMR (DMSO-d6, 100 °C, 75 MHz) 
δ = 12.8, 21.1, 22.6, 27.6, 41.3, 43.5, 44.8, 45.5, 54.8, 55.0, 55.8, 64.1, 64.4, 78.1, 98.3, 104.7, 116.4, 
116.7, 128.7, 132.2, 132.8, 153.9, 155.0, 157.8, 159.8, 169.2, 174.6; HRMS (ESI-TOF) m/z calcd for 
C31H47N3NaO9 ([M + Na]
+): 628.3210, found: 628.3234. 
(S)-3-{[(9H-Fluoren-9-yl)methoxycarbonyl]amino}-4-{[2-ethyl(tert-butoxycarbonyl)aminoethyl] [2,4-
dimethoxybenzyl]amino}-2,2-dimethyl-4-oxobutanoic acid 27. Carboxylic acid 27 was prepared from 
amide 26 (55.9 mg, 92.3 μmol) in a manner similar to that described for 10a. 27 (64.7 mg, 92.0 μmol, 
quant.) was obtained as pale yellow amorphous. [α]25D -1.5 (c 0.80, CHCl3); IR (CHCl3): vmax, cm−1: 1160, 
1210, 1455, 1508, 1616, 1643, 1692, 1718, 2928, 2973, 3277; 1H-NMR (DMSO-d6, 100 °C, 300 MHz) δ 
= 0.10 (3H, t, J = 7.1 Hz), 1.12 (3H, s), 1.22 (1H, s), 1.38 (9H, s), 3.10–3.44 (6H, br m), 3.72 (3H, s), 3.77 
(3H, s), 4.07–4.25 (1H, br m), 4.25–4.41 (2H, br m), 4.41–4.61 (2H, br m) 4.81 (1H, br d, J = 6.2 Hz), 
6.42 (1H, dd, J = 8.3, 2.0 Hz), 6.55 (1H, d, J = 2.0 Hz), 7.25–7.36 (2H, m), 7.40 (2H, dd, J = 7.3, 7.5 Hz), 
7.67 (2H, d, J = 7.0 Hz), 7.84 (2H, d, J = 7.3 Hz); 13C-NMR (DMSO-d6, 75 MHz, rotamer)
23 δ =13.5, 
20.8, 20.9, 24.1, 24.3, 28.0, 42.8, 43.6, 44.8, 45.8, 46.6, 46.7, 55.0, 55.2, 55.3, 55.7, 65.9, 66.0, 78.5, 78.7, 
98.2, 98.3, 104.3, 104.4, 116.4, 116.9, 120.1, 125.3, 125.4, 127.0, 127.3, 127.7, 128.9, 140.7, 143.5, 143.6, 
143.8, 156.0, 156.3, 157.8, 158.0, 159.6, 159.9, 169.9, 177.6, 177.7; HRMS (ESI-TOF) m/z calcd for 
C39H49N3NaO9 ([M + Na]
+): 726.3367, found: 726.3365. 
Synthesis of 29 for preparation of peptide 19  
  
Allyl N2-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-N4-{2-[(tert-butoxycarbonyl)(ethyl)amino]ethyl}-N4 -
(2,4-dimethoxybenzyl)-L-asparaginate 28. To a stirred mixture of Fmoc-L-Asp(OH)-OAllyl
19 (350 mg, 
0.886 mmol) and 14b (250 mg, 0.739 mmol) in CH2Cl2 (10 mL) was added EDC·HCl (170 mg, 0.886 
mmol) at 0 °C. The reaction mixture was stirred at room temperature for 1 h and diluted with EtOAc and 
5% KHSO4 aq. The solution was extracted three times with EtOAc. The combined organic layer was 
washed with brine, sat. NaHCO3 aq. and brine, dried over MgSO4, filtrated and concentrated in vacuo. 
The obtained crude material was purified with column chromatography (n-hexane/EtOAc = 1/1) to afford 
amide 28 (500 mg, 0.698 mmol, 95%) as pale yellow oil. [α]28D 22.8 (c 2.13, CHCl3); IR (CHCl3): vmax, 
cm−1: 1289, 1454, 1506, 1642, 1690, 1725, 2838, 2934, 2972, 3438; 1H-NMR (DMSO-d6, 100 °C, rotamer, 
300 MHz) δ =1.01 (3H, t, J = 7.0 Hz), 1.39 (9H, s), 2.89–2.95 (2H, m), 3.09–3.23 (4H, m), 3.33 (2H, br 
t, J = 6.3 Hz), 3.75 (3H, s), 3.79 (3H, s), 4.20–4.28 (1H, m), 4.30–4.36 (2H, m), 4.38–4.51 (2H, m), 4.56–
4.63 (3H, m), 5.18 (1H, dd, J = 10.4, 1.5 Hz), 5.31 (1H, dd, J = 17.2, 1.5 Hz), 5.89 (1H, ddt, J = 17.2, 
10.4, 5.3 Hz), 6.47 (1H, br d, J = 8.2 Hz), 6.58 (1H, s), 7.02 (1H, d, J =, 8.2 Hz), 7.05–7.21 (1H, m), 7.31 
(2H, dd, J = 7.5, 7.1 Hz), 7.41 (2H, dd, J = 7.5, 7.1 Hz), 7.67 (2H, d, J = 7.3 Hz), 7.85 (2H, d, J = 7.5 Hz); 
13C-NMR (DMSO-d6, 75 MHz, rotamer)
20 δ =13.3, 13.8, 28.0, 34.0, 34.7, 41.5, 42.1, 42.7, 43.6, 44.7, 
44.9, 46.3, 46.6, 50.5, 50.9, 55.1, 55.2, 55.3, 55.4, 64.9, 65.0, 65.8, 78.4, 78.9, 98.2, 98.5, 104.3, 104.5, 
116.3, 117.4, 117.6, 120.1, 125.2, 127.1, 127.6, 128.2, 128.4, 128.9, 132.3, 132.4, 140.7, 143.7, 155.7, 
155.8, 157.9, 159.7, 160.2, 169.1, 169.6, 171.1, 171.3; HRMS (ESI-TOF) m/z calcd for C40H49N3NaO9 
([M + Na]+):738.3367, found: 738.3389. 
 N2-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-N4-{2-[(tert-butoxycarbonyl)(ethyl)amino]ethyl}-N4-(2,4-
dimethoxybenzyl)-L-asparagine 29. To a solution of amide 28 (450 mg, 0.629 mmol) in THF (6.0 mL) 
was added Pd(PPh3)4 (72.7 mg, 62.9 μmol) and N-methylaniline (685 μL, 6.29 mmol). The reaction 
mixture was stirred at room temperature for 1 h and concentrated in vacuo. The obtained crude material 
was purified with column chromatography (n-hexane/EtOAc = 1/1 then EtOAc/MeOH = 10/1) to afford 
carboxylic acid 29 (394 mg, 0.583 mmol, 93%) as pale yellow amorphousness. [α]28D 39.5 (c 1.26, 
CHCl3); IR (CHCl3): vmax, cm
−1: 1289, 1506, 1610, 1643, 1690, 1718, 2843, 2972, 3314, 3427; 1H-NMR 
(DMSO-d6, 120 °C, rotamer, 300 MHz) δ =1.02 (3H, t, J = 7.0 Hz), 1.40 (9H, s), 2.86–2.96 (2H, m), 3.15 
(2H, q, J = 7.0 Hz), 3.19–3.27 (2H, br m), 3.30–3.42 (2H, br m), 3.75 (3H, s), 3.80 (3H, s), 4.20–4.29 (1H, 
m), 4.29–4.35 (2H, m), 4.42–4.58 (3H, m), 6.47 (1H, dd, J = 8.4, 2.2 Hz), 6.58 (1H, d, J = 2.2 Hz), 6.86 
(1H, br d, J = 7.5 Hz), 7.04 (1H, d, J = 8.4 Hz), 7.31 (2H, dd, J = 7.5, 7.0 Hz), 7.41 (2H, dd, J = 7.5, 7.0 
Hz), 7.68 (2H, d, J = 7.5 Hz), 7.84 (2H, d, J = 7.5 Hz); 13C-NMR (DMSO-d6, 75 MHz, rotamer)
20 δ =13.2, 
13.8, 28.0, 33.9, 34.6, 41.5, 42.2, 42.8, 43.6, 44.0, 44.4, 44.9, 45.3, 46.4, 46.6, 50.5, 50.8, 55.1, 55.2, 55.3, 
65.8, 66.3, 78.4, 78.7, 78.9, 98.1, 98.5, 104.3, 104.5, 116.4, 117.1, 120.1, 125.2, 127.1, 127.6, 128.2, 
128.4, 128.7, 140.7, 143.8, 154.1, 154.6, 155.7, 155.8, 157.9, 159.7, 160.1, 169.4, 169.8, 172.9, 173.2; 
HRMS (ESI-TOF) m/z calcd for C37H45N3NaO9 ([M + Na]
+): 698.3054, found: 698.3051. 
General procedures for peptide synthesis 
Fmoc-based solid-phase peptide synthesis (Fmoc SPPS). On NovaSyn® TGR resin (0.22 mmol 
amine/g) were coupled Fmoc protected naturally occurring amino acid derivatives (5.0 eq., a protective 
group of a side chain: t-Bu for serine and tyrosine) in the presence of N,N’-diisopropylcarbodiimide (DIC, 
5.0 eq.) and 1-hydroxybenzotriazole hydrate (HOBt·H2O, 5.5 eq.) in DMF for 2 h. Coupling of asparagine 
derivatives 10a, 16, 10b or 27 (2 eq.) was performed using O-(7-azabenzotriazol-1-yl)-N,N,N’,N’-
tetramethyluronium hexafluorophosphate (1.95 eq.) and N,N-diisopropylethyamine (4.0 eq.) for 2 h. For 
Fmoc removal of the peptide resin, 20% (v/v) piperidine in DMF (10 min) was employed.  
 TFA cleavage. The resulting completed resin was treated with TFA/m-cresol/1,2-
ethanedithiol/thioanisole/H2O (80/5/5/5/5 (v/v)) for 2 h at room temperature otherwise noted. After 
filtration of the resin, cooled Et2O was added to the filtrate, and the resulting precipitate was collected by 
centrifugation. The obtained precipitate was washed with Et2O and was purified by semi-preparative 
HPLC to give peptides. 
 
Preparation of model peptides 11a, 18, 11b, 19 and 20 
Peptides were synthesized according to the section “Fmoc-based solid-phase peptide synthesis” 
Fmoc SPPS using 10a. Peptide 11a (major peak): a white lyophilized powder (2.08 mg, 1.19 μmol, 
6.2%); retention time = 16.2 min (Analytical HPLC conditions: linear gradient of solvent B in solvent A, 
38 to 50% over 30 min); retention time = 24.2 (Semi-preparative HPLC conditions: linear gradient of 
solvent B in solvent A, 38 to 50% over 30 min); LRMS (ESI-TOF) m/z calcd for C86H113N17O21 ([M + 
2H]2+): 859.9, found: 859.7. Peptide 18 (minor peak): a white lyophilized powder (1.30 mg, 0.699 μmol, 
3.9%); retention time = 17.6 min (Analytical HPLC conditions: linear gradient of solvent B in solvent A, 
38 to 50% over 30 min); retention time = 22.9 (Semi-preparative HPLC conditions: linear gradient of 
solvent B in solvent A, 38 to 50% over 30 min); LRMS (ESI-TOF) m/z calcd for C86H113N17O21 ([M + 
2H]2+): 859.9, found: 859.8. 
Fmoc SPPS using 16 isomer. Peptide 18: retention time = 16.3 min (Analytical HPLC conditions: linear 
gradient of solvent B in solvent A, 38 to 50% over 30 min); LRMS (ESI-TOF) m/z calcd for 
C86H113N17O21 ([M + 2H]
2+): 859.9, found: 859.8. 
Fmoc SPPS using 10b. Peptide 11b (major peak): a white lyophilized powder (0.75 mg, 0.411 μmol, 
8.2%); retention time = 18.9 min (Analytical HPLC conditions: linear gradient of solvent B in A, 25 to 
40% over 30 min); retention time = 21.4 (Semi-preparative HPLC conditions: linear gradient of solvent 
 B in solvent A, 27 to 42% over 30 min); LRMS (ESI-TOF) m/z calcd for C78H108N16O17 ([M + 2H]
2+): 
770.4, found: 770.2.  
 
Peptide 30 (minor peak): retention time = a white lyophilized powder (0.39 mg, 0.214 μmol, 4.3%); 
20.3 min (Analytical HPLC conditions: linear gradient of solvent B in solvent A, 25 to 40% over 30 min); 
retention time = 23.0 (Semi-preparative HPLC conditions: linear gradient of solvent B in solvent A, 27 to 
42% over 30 min); LRMS (ESI-TOF) m/z calcd for C78H108N16O17 ([M + 2H]
2+): 770.4, found: 770.3. 
Fmoc SPPS using 27. Peptide 30: retention time = 20.3 min (Analytical HPLC conditions: linear 
gradient of solvent B in solvent A, 25 to 40% over 30 min); LRMS (ESI-TOF) m/z calcd for 
C78H108N16O17 ([M + 2H]
2+): 770.4, found: 770.2. 
Fmoc SPPS using 29. Peptide 19: a white lyophilized powder (12.0 mg, 6.70 μmol, 50%); retention 
time = 20.4 min (Analytical HPLC conditions: linear gradient of solvent B in solvent A, 30 to 40% over 
30 min); retention time = 24.3 (Semi-preparative HPLC conditions: linear gradient of solvent B in solvent 
A, 27 to 41% over 30 min); LRMS (ESI-TOF) m/z calcd for C76H104N16O17 ([M + 2H]
2+): 756.4, found: 
756.3. 
Fmoc SPPS using Fmoc-Asn(OtBu)-OH Peptide 20: a white lyophilized powder (8.32 mg, 5.26 μmol, 
53%); retention time = 23.5 min (Analytical HPLC conditions: linear gradient of solvent B in solvent A, 
5 to 60% over 30 min); retention time = 28.0 (Semi-preparative HPLC conditions: linear gradient of 
solvent B in solvent A, 28 to 42% over 30 min); LRMS (ESI-TOF) m/z calcd for C72H95N15O17 ([M + 
H]+): 1440.7, found: 1441.0. 
 
Self-processing of peptide 11b, 19 and 20 
 Self-processing of peptide 11b. A solution of model peptide 11b (45.0 μg, 25.9 nmol) and benzene 
sulfonic acid sodium salt (internal standard, 20.7 ng, 0.115 nmol) in phosphate buffer (0.2 M, pH 7.4 and 
7.9, 550 μL) containing 6 M guanidine hydrochloride was incubated at 37 °C and the reaction was 
monitored by analytical HPLC. Analytical HPLC conditions: a linear gradient of solvent B in solvent A, 
1 to 60% over 30 min. 
The remaining substrate was calculated based on peak areas (= A) of HPLC as follow. At = 0 indicates 
peak areas at beginning of the reaction (t = 0). 
Remaining substrate (%) =  
𝐴substrate / 𝐴internal standard 
𝐴substrate
𝑡=0  / 𝐴internal standard
𝑡=0  
 × 100 
11b: retention time = 21.9 min. 
23 or 24: retention time = 16.4 min; LRMS (ESI-TOF) m/z calcd for C38H57N8O9 ([M + H]
+): 769.4, 
found: 769.3. 
23 or 24: retention time = 17.4 min; LRMS (ESI-TOF) m/z calcd for C38H57N8O9 ([M + H]
+): 769.4, 
found: 769.3. 
22: retention time = 20.1 min; LRMS (ESI-TOF) m/z calcd for C40H53N8O9 ([M + H]
+): 789.4, found: 
789.2. 
Benzene sulfonic acid sodium salt (internal standard): retention time = 7.5 min.  
 
Self-processing of peptide 19 
 
Procedure of self-processing of 19 was conducted as similar to that described for 11b (pH = 7.9). 
 19: retention time = 21.9 min. 
31 or 32: retention time = 15.6 min; LRMS (ESI-TOF) m/z calcd for C36H53N8O9 ([M + H]
+): 741.4, 
found: 741.3. 
31 or 32: retention time = 16.3 min; LRMS (ESI-TOF) m/z calcd for C36H53N8O9 ([M + H]
+): 741.4, 
found: 741.3. 
Self-processing of peptide 20. Procedure of self-processing of 20 was conducted as similar to that 
described for 11b (pH = 7.9). Almost no splitted peptide was observed within 24 h. 
20: retention time = 23.5 min. 
 
Photo-responsible amide bond cleavage of peptide 11a 
Photo-responsible peptide 11a (45.0 μg, 24.2 nmol) and benzene sulfonic acid sodium salt (internal 
standard, 3.00 ng, 16.7 pmol) in phosphate buffer (0.2 M, pH 7.4, 515 μL) containing 6 M guanidine 
hydrochloride was incubated at 37 °C for 24 h, and the reaction mixture was then irradiated by UV (>365 
nm) for 1 min. The resulting solution was incubated at 37 °C. The reaction was monitored by analytical 
HPLC. Analytical HPLC conditions: a linear gradient of solvent B in solvent A, 1 to 60% over 30 min. 
11a: retention time = 28.2 min. 
 
 
Supporting Information Available:  
This material is available free of charge via the Internet at http://pubs.acs.org. 1H and 13C NMR spectra 
for new compounds. 
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